tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Opthea Limited Sponsored ADR (OPT)
NASDAQ:OPT
US Market
OPT
Opthea Limited Sponsored ADR
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Ownership
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
OPT Chart

Opthea Limited Sponsored ADR (OPT) Stock News & Sentiment

Compare
198 Followers
Hold Rating Issued for Opthea Limited Amid Uncertainty Following Phase 3 Trial Failure
Premium
Ratings
Hold Rating Issued for Opthea Limited Amid Uncertainty Following Phase 3 Trial Failure
1M ago
OPT
Opthea Limited: Hold Rating Amid Phase 3 Trial Failure and Financial Uncertainty
Premium
Ratings
Opthea Limited: Hold Rating Amid Phase 3 Trial Failure and Financial Uncertainty
1M ago
OPT
Opthea’s COAST Phase 3 Trial Fails to Meet Primary Endpoint, Raising Financial Concerns
Premium
Company Announcements
Opthea’s COAST Phase 3 Trial Fails to Meet Primary Endpoint, Raising Financial Concerns
1M ago
6K
OPT
Opthea Limited: Promising Clinical Trials and Strong Financial Position Support Buy Rating with $13 Target
Premium
Ratings
Opthea Limited: Promising Clinical Trials and Strong Financial Position Support Buy Rating with $13 Target
2M ago
OPT
Opthea Limited Reports Increased Losses Amid Clinical Advancements
Premium
Company Announcements
Opthea Limited Reports Increased Losses Amid Clinical Advancements
2M ago
OPT
Optimistic Buy Rating for Opthea Limited Driven by Promising Phase 3 Trials and Innovative AMD Treatment
Premium
Ratings
Optimistic Buy Rating for Opthea Limited Driven by Promising Phase 3 Trials and Innovative AMD Treatment
2M ago
OPT
Optimistic Outlook and Buy Rating for Opthea Limited Amid Promising Phase 3 Trials and Strong Financial Position
Premium
Ratings
Optimistic Outlook and Buy Rating for Opthea Limited Amid Promising Phase 3 Trials and Strong Financial Position
2M ago
OPT
More OPT News >

OPT News on the Web

Opthea Limited (CKDXF) was downgraded to a Sell Rating at Bell Potter
TipRanks News
Neutral
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Opthea Limited Sponsored ADR (OPT) and Larimar Therapeutics (LRMR)
TipRanks News
Neutral
Exploring Three High Growth Tech Stocks In Australia
Yahoo Finance
Neutral
Opthea First Half 2025 Earnings: US$0.11 loss per share
Yahoo Finance
Neutral
Opthea Announces Phase 2b Wet AMD Publication
Yahoo Finance
Neutral
Opthea Reports Half Year Results and Business Updates
Yahoo Finance
Neutral
Opthea Completes Drug Product PPQ Campaign
Yahoo Finance
Neutral
Opthea Completes COAST Final Week 52 Patient Visit
Yahoo Finance
Neutral

News Score - Last 7 Days

Neutral
OPT
Sector Average
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
This Week59%
Sector Average58%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is OPT’s Media Buzz Sentiment?
Currently, no data Available
What is OPT’s weekly average amount of articles?
Currently, no data Available
What is OPT’s News Sentiment?
59% of articles about OPT were positive this week, compared to its sector average of 58%.
    Healthcare Stocks that are Trending in the News
    SWTXSpringworks Therapeutics
    URGNUrogen Pharma
    JAGXJaguar Animal Health
    HRTXHeron Therapeutics
    EWEdwards Lifesciences
    Showing the stocks with the most bullish news sentiment over the past week

    Become an Expert with TipRanks Premium

    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis
    Subscribe NowSee Plans & Pricing